TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: Satcher Names CDC Director; POG Appoints Monaco To Data Monitoring Committee September 10, 1993